aTyr Pharma, Inc. Common Stock

ATYRNASDAQUSD
0.57 USD
0.04 (7.55%)AT CLOSE (11:59 AM EDT)
0.57
0.00 (0.18%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
0.57
0.00 (0.18%)
🟢Market: OPEN

aTyr Pharma, Inc. Common Stock (ATYR) is currently trading at $0.57. ATYR shows a split signal: technical indicators suggest "Strong Buy" while underlying fundamentals indicate "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation metrics place ATYR at a fair price relative to peers.

Technical & fundamental data as of Aug 25, 2026.

Open?$0.54
High?$0.57
Low?$0.53
Prev. Close?$0.53
Volume?676.9K
Avg. Volume?924.2K
VWAP?$0.55
Rel. Volume?0.73x
Bid / Ask
Bid?$0.48 × 100
Ask?$0.65 × 100
Spread?$0.17
Midpoint?$0.57
Valuation & Ratios
Market Cap?52.0M
Shares Out?98.1M
Float?95.6M
Float %?97.5%
P/E Ratio?N/A
P/B Ratio?0.90
EPS?-$0.71
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).
Employees
58
Market Cap
52.0M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2015-05-07
Address
10240 SORRENTO VALLEY ROAD
SAN DIEGO, CA 92121
Phone: (858) 731-8389
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bullish(+1/3)
Medium-Term (Wave)? Bullish(+3/3)
Short-Term (Ripple)? Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
50
Short Sent.?
28
Piotroski F-Score?0/9Weak
Altman Z-Score?-11.61Distress
Confidence?48%Low
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?9.88%Elevated
Short Interest?9.4M
Days to Cover?14.7
Free Float95.6M
Avg Daily Volume641.2K
Settlement Date2026-08-14
Financial Health
Current Ratio?5.78Strong
Quick Ratio?5.78Strong
Cash Ratio?0.86Adequate
Debt/Equity?0.01Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A
P/B?
Peers
100
S&P
97
0.90CHEAP
P/S?
Peers
100
S&P
3
273.61HIGH
P/FCF?
N/A
EV/EBITDA?
S&P
97
-0.6CHEAP
EV/Sales?
Peers
100
S&P
3
224.87HIGH
Returns & Efficiency
ROE?
S&P
3
-120.9%WEAK
ROA?
S&P
3
-87.9%WEAK
Cash Flow & Enterprise
FCF?$-59298000
Enterprise Value?$42.7M
Fundamentals ratios updated end of day